Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
127,672,444
-
Total 13F shares
-
64,568,091
-
Share change
-
-210,142
-
Total reported value
-
$4,081,020,359
-
Put/Call ratio
-
86%
-
Price per share
-
$63.20
-
Number of holders
-
200
-
Value change
-
+$9,798,661
-
Number of buys
-
117
-
Number of sells
-
76
Institutional Holders of Apellis Pharmaceuticals, Inc. - Common Stock (APLS) as of Q2 2021
As of 30 Jun 2021 Apellis Pharmaceuticals, Inc. - Common Stock (APLS) had 200 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 64,568,091 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, HHLR ADVISORS, LTD., JENNISON ASSOCIATES LLC, BAKER BROS. ADVISORS LP, STATE STREET CORP, VICTORY CAPITAL MANAGEMENT INC, and Farallon Capital Management LLC.
This table shows 201 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.